OVERVIEW
The global market for oligonucleotide synthesis is expected to hit USD 9.3 billion by 2025, rising over the forecast period at a CAGR of 13.12%. Due to the increasing research activities in the pharmaceutical and biotech sectors and the increasing demand for novel diagnostic and therapeutic techniques, this market is experiencing significant growth.
TABLE OF CONTENT
1 Global Oligonucleotide Synthesis Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Oligonucleotide Synthesis Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Oligonucleotide Synthesis Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Oligonucleotide Synthesis Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Oligonucleotide Synthesis Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Oligonucleotide Synthesis Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Oligonucleotide Synthesis Market – By Product & Type (Market Size – &
million/billion)
8.1 Product
8.1.1 Oligonucleotide-based Drugs
8.1.2 Primers
8.1.3 Probes
8.1.4 Large-scale Synthesized Oligonucleotides
8.2 Type
8.2.1 Custom Oligonucleotides
8.2.2 Pre-designed Oligonucleotides
9 Global Oligonucleotide Synthesis Market – By Application
9.1 Research
9.2 Diagnostics
9.3 Therapeutics
10 Global Oligonucleotide Synthesis Market – By End User
10.1 Academic & Research Institutes
10.2 Pharmaceutical & Biotechnology Companies
10.3 Diagnostic Laboratories
10.4 Hospitals
11 Global Oligonucleotide Synthesis Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Oligonucleotide Synthesis Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Oligonucleotide Synthesis Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Agilent Technologies
13.3 GE Healthcare
13.4 Adtbio
13.5 Bioautomation (Acquired By LGC)
13.6 Bio-Synthesis Inc.
13.7 Genscript
13.8 Genedesign (Part of Ajinomoto)
13.9 Biogen
13.10 Eurofins Genomics
13.11 Eurogentec
13.12 Company 11 & more
14 Global Oligonucleotide Synthesis Market – Appendix
14.1 Sources
14.2 Abbreviations